Roquette Executive and Leadership Team

Armand Chen, the Roquette Chief Operating Officer and Qualicaps Chief Executive Officer at Roquette, directs global manufacturing excellence and operational efficiency across all plant-based ingredient production lines. Overseeing the integration of Qualicaps into the broader corporate portfolio, the Chief Operating Officer ensures seamless alignment between pharmaceutical capsule technology and core food nutrition business units. This leadership role involves optimizing supply chain logistics to maintain high-performance standards for international markets. By streamlining production processes, Armand Chen drives significant improvements in resource utilization and output quality. The Chief Operating Officer maintains rigorous oversight of industrial safety protocols while fostering innovation in bio-based manufacturing. Through strategic coordination with regional plant managers, Chen secures operational stability and supports the long-term growth objectives of the organization, ensuring that every facility meets the stringent requirements of the global health and nutrition sectors.

Brendon Boland, the Chief Financial Officer at Roquette, manages the global fiscal strategy and capital allocation for the entire organization. Overseeing financial planning, risk management, and investor relations, the Chief Financial Officer ensures the company maintains a robust balance sheet to support ongoing research and development in plant-based ingredients. This leadership role involves analyzing market trends to guide investment decisions in sustainable infrastructure and new product development. By implementing advanced financial reporting systems, Brendon Boland provides the executive team with actionable insights into profitability and cost efficiency. The Chief Financial Officer coordinates closely with the Board to align fiscal policies with the long-term mission of improving quality of life through nutrition. Boland drives the financial health of the enterprise, ensuring that capital resources effectively support the expansion of pharmaceutical solutions and bio-based product lines across diverse international markets.

Vincent Claps, the Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions at Roquette, manages the financial performance and budgetary oversight for the pharmaceutical solutions division. Overseeing divisional revenue forecasting, cost control, and investment analysis, the Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions ensures that the business unit achieves its profitability targets. This leadership role involves providing financial guidance to the pharma leadership team to support the development of excipients and drug delivery systems. By optimizing the financial structure of the division, Vincent Claps enables the efficient allocation of funds toward high-growth pharmaceutical projects. The Vice President, Finance & Divisional Chief Financial Officer, Pharma Solutions collaborates with corporate finance to ensure alignment with overall company fiscal goals. Claps drives the financial integrity of the pharma division, supporting the delivery of essential health solutions to global markets through disciplined fiscal management.

Brian Albright, the Chief Operating Officer, Roquette Health & Pharma at Roquette, directs the strategic execution of pharmaceutical excipient production and health-focused ingredient development. Overseeing the specialized manufacturing processes required for oral medicines and biopharmaceutical applications, the Chief Operating Officer ensures compliance with global regulatory standards. This leadership role involves managing the technical teams responsible for high-performance solutions that serve the health industry. By coordinating with research departments, Brian Albright accelerates the transition of innovative plant-based compounds from laboratory development to commercial scale. The Chief Operating Officer monitors operational performance across key pharmaceutical hubs to guarantee consistent product quality and supply chain reliability. Albright drives the growth of the health and pharma division, ensuring that the company remains a preferred partner for pharmaceutical manufacturers worldwide while maintaining a commitment to sustainable and responsible resource use.